课题基金 / 基金详情

Regulatory roles of heme oxygenase-1 in autoinflammation and autoimmunity as a model of Behcet's disease

Regulatory roles of heme oxygenase-1 in autoinflammation and autoimmunity as a model of Behcet's disease
血红素加氧酶-1 在白塞氏病模型自身炎症和自身免疫中的调节作用
批准号:
23591443
负责人:
TAKENO Mitsuhiro
金额:
$3.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

TAKENO Mitsuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
在本研究中,我们试图验证一种假设,即IL-10/HO-1损害保护功能会触发自身免疫和自体炎症反应,从而导致白塞病(BD)。进一步的分析表明CCR1、STAT4、KLRC4、ERAP1、TLR4、NOD2和MEFV是易感基因,所有这些基因都与获得性免疫系统和先天免疫系统有关。其中,TLR4的遗传贡献与我们先前的发现一致,即TLR4的过度表达与BD患者HO-1的表达缺陷有关,这表明该假说在一定程度上是正确的。此外,最近的研究表明,HO-1在非经典的M2巨噬细胞上优先表达,这表明M1/M2平衡的偏离是BD发生的原因。这一问题将在下一笔赠款(26461469号)中进行研究。
英文摘要
In this study, we try to verify the hypothesis that impaired protective function by IL-10/HO-1 trigger autoimmune and autoinflammatory responses, leading to Behcet disease (BD). Further analyses after GWAS have identified CCR1, STAT4, KLRC4, ERAP1, TLR4, NOD2, and MEFV as susceptible genes, all of which are involved in the acquired and innate immunity systems. Of them, genetic contribution of TLR4 is concordant with our previous finding that overexpression of TLR4 is associated with defective expression of HO-1 in BD patients, suggesting validity of the hypothesis in part. Moreover, recent studies have shown that HO-1 is preferentially expressed on non-classical M2 macrophages, suggesting M1 deviation of M1/M2 balance is responsible for development of BD. The issue will be studied in the next grant (No. 26461469).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunogenicity of infliximab modulates efficacy and safety in Behcet's disease patients with uveitis. American College of Rheumatology
英夫利昔单抗的免疫原性调节白塞氏病合并葡萄膜炎的疗效和安全性。
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Takeno M, et al]
通讯作者: et al
ベーチェット病の免疫異常と治療の進歩
白塞氏病的免疫异常和治疗进展
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Yuichi Makino, Hidemitsu Sakagami, Hiroya Kitsunai, Shuhei Tomita, Kensaku Okamoto, Yukihiro Fujita, Yumi Takiyama, and Masakazu Haneda, 岳野光洋,他]
通讯作者: 岳野光洋,他
ヒト単球におけるBach1によるheme oxygenase-1の発現調節. ,
Bach1 对人单核细胞中血红素加氧酶 1 表达的调节。
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [岳野光洋, 宮崎拓也, 桐野洋平, 渡邉玲光, 寒川整, 高瀬薫, 浜真麻, 石ヶ坪良明:]
通讯作者: 石ヶ坪良明:
Infliximab therapy for uveitis in Behçet's disease.
英夫利昔单抗治疗白塞病葡萄膜炎。
DOI: --
发表时间:
期刊:
影响因子: --
作者: [Terauchi K, Takeno M, Shibuya E, Mizuki N, Ishigatsubo Y.]
通讯作者: Ishigatsubo Y.
47
    Regulation of heme oxygenase-1 expression and the therapeutic application in rheumatic and inflammatory diseases
    • 批准号:
      20591174
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      TAKENO Mitsuhiro
    • 依托单位:
    Development of novel therapeutic strategies for rheumatoid arthritis based on the neuro - endocrine-immune axis
    • 批准号:
      12670442
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      TAKENO Mitsuhiro
    • 依托单位:
    Fas ligands peripheral lymphocytes from patients with systemic lupus erythematosus
    • 批准号:
      09670497
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1998
    • 负责人:
      TAKENO Mitsuhiro
    • 依托单位:
    海外基金